Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer

Br J Cancer. 2008 Aug 5;99(3):551-2. doi: 10.1038/sj.bjc.6604451. Epub 2008 Jul 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • ErbB Receptors / antagonists & inhibitors*
  • Genes, ras*
  • Humans
  • Mutation*
  • Neoplasm Metastasis

Substances

  • Antineoplastic Agents
  • ErbB Receptors